Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot 7632701, Israel.
Institute for Translational HIV Research, University Hospital Essen, University of Duisburg-Essen, Essen 45147, Germany.
Biochemistry. 2022 Sep 6;61(17):1915-1922. doi: 10.1021/acs.biochem.2c00372. Epub 2022 Aug 22.
The HIV envelope protein gp160 comprises two subunits, gp120 and gp41, responsible for receptor binding and membrane fusion during viral entry, respectively. In the course of the membrane fusion process, gp41 undergoes a conformational change, leading to the formation of a six-helix bundle (SHB), which ultimately drives membrane fusion. The gp41 C-terminal and N-terminal heptad repeats (CHR and NHR) interact with one another to form the SHB, and this step can be targeted by peptide inhibitors, which are used in the clinic to mitigate HIV infection. Here, we discover the calcium interaction motifs (CIMs) in the gp41 CHR and NHR regions NMR spectroscopy. We find that the assembly of the CHR-NHR SHB is facilitated in Ca-containing media and impaired in CIM mutants. Of note, the clinically approved, gp41-derived fusion inhibitor T20, which does not contain the CIM motif, exhibits reduced inhibitory efficiency when challenged with calcium. This finding could have important implications for the development of better fusion inhibitors for HIV.
HIV 包膜蛋白 gp160 由两个亚单位 gp120 和 gp41 组成,分别负责病毒进入时的受体结合和膜融合。在膜融合过程中,gp41 发生构象变化,导致形成六螺旋束(SHB),最终驱动膜融合。gp41 的 C 端和 N 端七肽重复(CHR 和 NHR)相互作用形成 SHB,这一步可以被肽抑制剂靶向,肽抑制剂在临床上用于减轻 HIV 感染。在这里,我们通过 NMR 光谱发现了 gp41 CHR 和 NHR 区域中的钙相互作用基序(CIM)。我们发现,在含有钙的介质中,CHR-NHR SHB 的组装得到促进,而在 CIM 突变体中则受到损害。值得注意的是,临床上批准的、源自 gp41 的融合抑制剂 T20 不含 CIM 基序,当受到钙挑战时,其抑制效率降低。这一发现可能对开发更好的 HIV 融合抑制剂具有重要意义。